RDGT(Ridgetech, Inc.) · 财务报表

RDGT(Ridgetech, Inc.) 的财务报表:医疗保健,药品零售。数据来自 SEC 公开申报与市场行情,不构成投资建议。

近年年度财务(SEC XBRL)
科目FY 截至 2022-03-31FY 截至 2023-03-31FY 截至 2024-03-31FY 截至 2025-03-31FY 截至 2026-03-31
营业收入$164.39M$148.81M$123.99M$119.97M$132.16M
毛利润$36.52M$3.60M$4.88M$3.84M$4.75M
营业利润−$2.69M−$13.16M$596.08K−$1.04M−$1.87M
净利润−$3.19M−$21.14M−$4.23M$10.19M−$1.25M
经营现金流−$5.39M−$3.28M−$3.16M$1.25M−$1.39M
自由现金流−$5.48M−$3.40M−$3.49M$1.09M−$1.39M
摊薄每股收益$-2752.50$-6219.00$-439.78$275.87$-17.21

Ridgetech, Inc. RDGT